People with cancer that has spread to only a few locations—called oligometastatic cancer—may benefit from aggressive local treatment.
by Kate Yandell
Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.
Studies indicate that many people with cancer have an antibody response to the vaccines, but this response may be reduced or absent in certain patients.
In her new book, Cancer Support Community executive chair Kim Thiboldeaux offers advice to patients on how to steer their way through a cancer diagnosis, treatment and beyond.
Gastrointestinal oncologist and health services researcher Ryan Nipp discusses new research about how muscle quality correlates with cancer outcomes.
While melanoma is less common than skin cancers like basal cell carcinoma or squamous cell carcinoma, it is much more deadly.
President Joseph R. Biden reaffirmed his administration’s support for the cancer research community.
Several factors contribute to the high mortality rates of brain cancer, including the aggressive nature of the disease and impediments to treatment.
Learning Medicare’s ABCDs
donate to the AACR
The AACR Cancer Progress Report 2020, which is published annually by the American Association for Cancer Research, tracks recent developments that impact cancer care. Click “Progress Report” below to find out more.